Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
BVSBioventus Inc.
| Figure | BVSBioventus Inc.FY2025 · Dec |
|---|---|
| Revenue | $568.09M |
| Revenue, yoy | −0.9% |
| Net income | $22.73M |
| Net income, yoy | +167.8% |
| Net margin | 4.0% |
| Free cash flow | $72.11M |
| FCF margin | 12.7% |
| EPS, diluted | $0.33 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed